WallStreetZen

NYSE: ZTS
Zoetis Inc Stock Forecast, Predictions & Price Target

OverviewForecast
EarningsDividendOwnership

Analyst price target for ZTS

Based on 6 analysts offering 12 month price targets for Zoetis Inc.
Min Forecast
$180.00-19.27%
Avg Forecast
$214.67-3.72%
Max Forecast
$264.00+18.4%

Should I buy or sell ZTS stock?

Based on 7 analysts offering ratings for Zoetis Inc.
Strong Buy
Strong Buy
4 analysts 57.14%
Buy
1 analysts 14.29%
Hold
2 analysts 28.57%
Sell
0 analysts 0%
Strong Sell
0 analysts 0%

ZTS stock forecasts by analyst

Analyst / FirmRatingActionPrice TargetUpside/DownsideDateAnalyst Color
Morgan Stanley
Top 4%
97
Strong BuyInitiates Coverage On$264.00+18.40%2021-11-18
Anonymous
Barclays
Strong BuyMaintains$240.00+7.64%2021-11-05
Credit Suisse
Top 29%
72
BuyMaintains$230.00+3.15%2021-08-09
Barclays
Bottom 10%
10
Strong BuyMaintains$235.00+5.40%2021-08-06
Raymond James
Bottom 10%
10
HoldDowngradesN/AN/A2021-07-16
Argus Research
Top 14%
87
Strong BuyMaintains$195.00-12.54%2021-05-28
Citigroup
Top 43%
58
HoldMaintains$184.00-17.48%2021-05-12
Bank of America
Bottom 10%
10
Strong BuyUpgrades$180.00-19.27%2021-03-08

1 of 1

Forecast return on equity

Is ZTS forecast to generate an efficient return?
Company
65.73%
Industry
91.37%
Market
37.06%
ZTS's Return on Equity is forecast to be high in 3 years (65.73%); analysts are confident in the firm's ability to efficiently generate return on equity
Forecast

Forecast return on assets

Is ZTS forecast to generate an efficient return on assets?
Company
22.44%
Industry
77.04%
ZTS is forecast to generate lower Return on Assets (22.44%) than the US Drug Manufacturers - Specialty & Generic industry average (77.04%)
Forecast

ZTS earnings per share forecast

What is ZTS's earnings per share in the next 3 years based on estimates from 9 analysts?
Avg 1 year Forecast
$4.53+8.63%
Avg 2 year Forecast
$5.13+23.02%
Avg 3 year Forecast
$5.94+42.45%
ZTS's earnings are forecast to grow at a rate of 12.16% per year, which is not exceptional
Forecast

ZTS revenue forecast

What is ZTS's revenue in the next 3 years based on estimates from 6 analysts?
Avg 1 year Forecast
$7.7B+1.51%
Avg 2 year Forecast
$8.4B+10.69%
Avg 3 year Forecast
$9.1B+19.77%
ZTS's revenue is forecast to grow at a rate of 6.2% per year, which is not exceptional
Forecast

ZTS earnings growth forecast

How is ZTS forecast to perform vs Drug Manufacturers - Specialty & Generic companies and vs the US market?
Company
12.16%
Industry
27.82%
Market
14.37%
ZTS's earnings are forecast to grow slower (12.16% per year) than the US Drug Manufacturers - Specialty & Generic industry average (27.82%)
Forecast
ZTS's earnings are forecast to grow slower (12.16% per year) than the US market average (14.37%)
Forecast
ZTS's earnings are forecast to grow faster (12.16% per year) than the risk-free savings rate (1.4%)
Forecast

ZTS revenue growth forecast

How is ZTS forecast to perform vs Drug Manufacturers - Specialty & Generic companies and vs the US market?
Company
6.2%
Industry
24.36%
Market
10.03%
ZTS's revenues are forecast to grow slower (6.2% per year) than the US Drug Manufacturers - Specialty & Generic industry average (24.36%)
Forecast
ZTS's revenues are forecast to grow slower (6.2% per year) than the US market average (10.03%)
Forecast

Zoetis Stock Forecast FAQ

Is Zoetis Stock a good buy in 2021, according to Wall Street analysts?

The consensus among 7 Wall Street analysts covering (NYSE: ZTS) stock is to Strong Buy ZTS stock.

Out of 7 analysts, 4 (57.14%) are recommending ZTS as a Strong Buy, 1 (14.29%) are recommending ZTS as a Buy, 2 (28.57%) are recommending ZTS as a Hold, 0 (0%) are recommending ZTS as a Sell, and 0 (0%) are recommending ZTS as a Strong Sell.

What is ZTS's earnings growth forecast for 2021-2023?

(NYSE: ZTS) Zoetis's forecast annual earnings growth rate of 12.16% is not forecast to beat the US Drug Manufacturers - Specialty & Generic industry's average forecast earnings growth rate of 27.82%, and while it is not forecast to beat the US market's average forecast earnings growth rate of 14.37%.

Zoetis's earnings in 2021 is $1,982,000,000.On average, 9 Wall Street analysts forecast ZTS's earnings for 2021 to be $2,143,259,974, with the lowest ZTS earnings forecast at $2,124,334,941, and the highest ZTS earnings forecast at $2,152,722,490. On average, 9 Wall Street analysts forecast ZTS's earnings for 2022 to be $2,427,135,467, with the lowest ZTS earnings forecast at $2,318,316,528, and the highest ZTS earnings forecast at $2,540,685,664.

In 2023, ZTS is forecast to generate $2,810,367,383 in earnings, with the lowest earnings forecast at $2,630,579,570 and the highest earnings forecast at $3,009,080,228.

What is ZTS's revenue growth forecast for 2021-2023?

(NYSE: ZTS) Zoetis's forecast annual revenue growth rate of 6.2% is not forecast to beat the US Drug Manufacturers - Specialty & Generic industry's average forecast revenue growth rate of 24.36%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 10.03%.

Zoetis's revenue in 2021 is $7,616,000,000.On average, 6 Wall Street analysts forecast ZTS's revenue for 2021 to be $3,657,899,904,542, with the lowest ZTS revenue forecast at $3,637,620,785,560, and the highest ZTS revenue forecast at $3,666,564,257,721. On average, 6 Wall Street analysts forecast ZTS's revenue for 2022 to be $3,988,490,422,029, with the lowest ZTS revenue forecast at $3,874,427,356,358, and the highest ZTS revenue forecast at $4,072,083,711,637.

In 2023, ZTS is forecast to generate $4,315,767,639,384 in revenue, with the lowest revenue forecast at $4,145,528,452,364 and the highest revenue forecast at $4,432,242,700,496.

What is ZTS's forecast return on assets (ROA) for 2021-2024?

(NYSE: ZTS) forecast ROA is 22.44%, which is lower than the forecast US Drug Manufacturers - Specialty & Generic industry average of 77.04%.

What is ZTS's Price Target?

According to 6 Wall Street analysts that have issued a 1 year ZTS price target, the average ZTS price target is $214.67, with the highest ZTS stock price forecast at $264.00 and the lowest ZTS stock price forecast at $180.00.

On average, Wall Street analysts predict that Zoetis's share price could stay at $214.67 by Nov 18, 2022. The average Zoetis stock price prediction forecasts a potential downside of N/A from the current ZTS share price of $222.97.

What is ZTS's Earnings Per Share (EPS) forecast for 2021-2023?

(NYSE: ZTS) Zoetis's current Earnings Per Share (EPS) is $4.17. On average, analysts forecast that ZTS's EPS will be $4.53 for 2021, with the lowest EPS forecast at $4.49, and the highest EPS forecast at $4.55. On average, analysts forecast that ZTS's EPS will be $5.13 for 2022, with the lowest EPS forecast at $4.90, and the highest EPS forecast at $5.37. In 2023, ZTS's EPS is forecast to hit $5.94 (min: $5.56, max: $6.36).

What is ZTS's forecast return on equity (ROE) for 2021-2024?

(NYSE: ZTS) forecast ROE is 65.73%, which is considered strong.
©2021 WallStreetZen
Company
AboutBlogPlansPrivacy PolicyTerms of ServiceCancellation & RefundsContact
Stocks
Stock ScreenerStock ForecastHighest Earnings StocksBest Dividend Paying StocksStatisticsTrending Stocks
Analysts
Top Performing Analysts
Social
TwitterYouTube
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.